휴마시스

205470KOSDAQ의료용품 및 기타 의약 관련제품 제조업

61.0 / 100

Reference Date: 2026-04-13

Financial Score28.5 / 40

News Sentiment15.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 11.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HumaSys operates in three main business segments: POCT immunoassay reagents for in vitro diagnostics, production of male condoms and medical devices, and entertainment services. The POCT division focuses on improving diagnostic products for COVID-19 and HIV, while the rubber products division produces a range of items according to international standards. The entertainment division generates revenue through artist management and content production. Major revenue streams come from POCT (13.4%), rubber products (19.5%), and entertainment services (46.2%).

Number of Employees

64people

Average Salary

47.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 19.894.0Point

PBR

0.45Industry Average 1.627.0Point

Half of industry avg (excellent)

ROE

-8.97Industry Average -4.893.5Point

1.8x industry avg (good)

Debt Ratio

0.35Industry Average 8.888.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲51.1% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲39.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -13.2% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 2Neutral 0Negative 0Average Sentiment Score 80

Positive
휴마시스, 보통주 600만주 주식소각 결정
휴마시스는 총 211억원 규모의 자기주식 600만주를 소각하기로 결정했으며, 이는 발행주식 수는 줄지만 자본금에는 변동이 없습니다.
Positive
휴마시스, 211억 규모 자사주 소각
휴마시스는 211억3348만원 규모의 자사주 600만주를 소각하기로 결정했으며, 이는 발행주식총수의 약 4.6%에 해당합니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (10%, downtrend)

Current 815Won52-week high 1,89952-week low 682

1-month return5.0Point

1m +11.04% (rising)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

17 totalPositive 0Neutral 17Negative 0

Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-04-09
Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-04-09
Neutral기타경영사항(자율공시)2026-04-09
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-07
Neutral주식등의대량보유상황보고서(일반)2026-04-03